Thomson Reuters

Reuters says CEO Jim Smith’s illness was an arrhythmia incident

As an update on Jim Smith, President and Chief Executive Officer of Thomson Reuters, the company said he remains under observation in a Toronto hospital.

Reuters disclosed in the statement that Jim Smith’s illness has been diagnosed as an arrhythmia incident on Monday, February 12.

Mr. Smith’s condition is stable and doctors expect a full recovery. It is expected that Mr. Smith will be released from the hospital within the next two weeks, followed by a period of further recovery.

In his immediate absence, Stephane Bello, Executive Vice President and Chief Financial Officer of Thomson Reuters, continues to oversee Mr. Smith’s responsibilities alongside his own, in line with the company’s practice.